Viking Global Investors
AMLX icon

Viking Global Investors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Viking Global Investors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,962,555
Closed -$43.6M – 84
2023
Q4 		$43.6M Hold
2,962,555
– – 0.16% 68
2023
Q3 		$54.2M Hold
2,962,555
– – 0.22% 65
2023
Q2 		$63.9M Hold
2,962,555
– – 0.26% 70
2023
Q1 		$86.9M Sell
2,962,555
-1,672,051
-36% -$58.1M 0.41% 46
2022
Q4 		$171M Sell
4,634,606
-1,135,930
-20% -$40.3M 0.86% 37
2022
Q3 		$162M Sell
5,770,536
-1,400,000
-20% -$34.9M 0.75% 39
2022
Q2 		$138M Hold
7,170,536
– – 0.63% 47
2022
Q1 		$92.1M Buy
+7,170,536
New +$162M 0.37% 65

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return